From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors

Ashkenazi, Avi, Fairbrother, Wayne J., Leverson, Joel D., Souers, Andrew J.·2017·Nature Reviews Drug Discovery
DOI 10.1038/nrd.2016.253

Cited by (918)

Items 101–200 of 918

  1. Synthesis, Antimicrobial, Anti-Virulence and Anticancer Evaluation of New 5(4H)-Oxazolone-Based Sulfonamides
    Ahmad J. Almalki, Tarek Salah Ibrahim, Ehab S. Taher, Mamdouh F. A. Mohamed, Mаhmoud Youns, Wael A. H. Hegazy, Amany M. M. Al‐Mahmoudy · 2022 · Molecules
  2. Discovery of a cryptic peptide-binding site on PCSK9 and design of antagonists
    Yingnan Zhang, Mark H. Ultsch, Nicholas J. Skelton, Daniel J. Burdick, Maureen H. Beresini, Wei Li, Monica Kong-Beltran, Andrew S. Peterson, John G. Quinn, Cecilia Chiu et al. · 2017 · Nature Structural & Molecular Biology
  3. Demethylzeylasteral inhibits cell proliferation and induces apoptosis through suppressing MCL1 in melanoma cells
    Yuzu Zhao, Jiang He, Jun Li, Xingzhi Peng, Xianxing Wang, Zhen Dong, Erhu Zhao, Yaling Liu, Zonghui Wu, Hongjuan Cui · 2017 · Cell Death and Disease
  4. Tyrosine Kinase Inhibitors Increase MCL1 Degradation and in Combination with BCLXL/BCL2 Inhibitors Drive Prostate Cancer Apoptosis
    Seiji Arai, Oliver H. Jonas, Matthew A. Whitman, Eva Corey, Steven P. Balk, Sen Chen · 2018 · Clinical Cancer Research
  5. Superior efficacy of cotreatment with BET protein inhibitor and BCL2 or MCL1 inhibitor against AML blast progenitor cells
    Warren C. Fiskus, Tianyu Cai, Courtney Denton Dinardo, Steven Mitchell Kornblau, Gautam M. Borthakur, Tapan Mahendra Kadia, Naveen Pemmaraju, Prithviraj Bose, Lucia Masárová, Kimal Rajapakshe et al. · 2019 · Blood Cancer Journal
  6. Cell death pathologies: targeting death pathways and the immune system for cancer therapy
    Francesca Pentimalli, Sandro Grelli, Nicola Di Daniele, Gerry Melino, Ivano Amelio · 2018 · Genes and Immunity
  7. MARCH5 mediates NOXA-dependent MCL1 degradation driven by kinase inhibitors and integrated stress response activation
    Seiji Arai, Andreas S. Varkaris, Mannan Nouri, Sen Chen, Lisha Xie, Steven P. Balk · 2020 · eLife
  8. Fucoidan Induces Apoptosis and Inhibits Proliferation of Hepatocellular Carcinoma via the p38 MAPK/ERK and PI3K/Akt Signal Pathways
    Yifei Duan, Jingjing Li, Xue Jing, Xueli Ding, Yanan Yu, Qingxi Zhao · 2020 · Cancer Management and Research
  9. Effects of Physical Exercise on Autophagy and Apoptosis in Aged Brain: Human and Animal Studies
    D. Andreotti, J. N. Silva, Amanda Midori Matumoto, A. Orellana, Paloma Segura De Mello, E. Kawamoto · 2020 · Frontiers in Nutrition
  10. Local delivery of a senolytic drug in ischemia and reperfusion-injured heart attenuates cardiac remodeling and restores impaired cardiac function
    Ju‐Ro Lee, Bong‐Woo Park, Jae-Hyun Park, Songhyun Lim, Sung Pil Kwon, Ji‐Won Hwang, Hyeok Kim, Hun‐Jun Park, Byung‐Soo Kim · 2021 · Acta Biomaterialia
  11. Fragment-based drug discovery supports drugging ‘undruggable’ protein–protein interactions
    Zhi-Zheng Wang, Xing-Xing Shi, Guang-Yi Huang, Ge‐Fei Hao, Guang‐Fu Yang · 2023 · Trends in Biochemical Sciences
  12. A BCL-xL/BCL-2 PROTAC effectively clears senescent cells in the liver and reduces MASH-driven hepatocellular carcinoma in mice
    Yang Yang, Natacha Jn‐Simon, Yonghan He, Chunbao Sun, Peiyi Zhang, Wanyi Hu, Tian Tian, Huadong Zeng, Sreenivasulu Basha, Araceli S. Huerta et al. · 2025 · Nature Aging
  13. Conversion of Bim-BH3 from Activator to Inhibitor of Bak through Structure-Based Design
    Jason M. Brouwer, Ping Lan, Angus D. Cowan, Jonathan P. Bernardini, Richard W. Birkinshaw, Mark F. van Delft, Brad E. Sleebs, Adeline Y. Robin, Ahmad Z. Wardak, Iris K. L. Tan et al. · 2017 · Molecular Cell
  14. Cell death-based treatment of glioblastoma
    Simone Fulda · 2018 · Cell Death and Disease
  15. A mini-review and perspective on ferroptosis-inducing strategies in cancer therapy
    Shuaifei Wang, Hongwei Liao, Fangyuan Li, Daishun Ling · 2019 · Chinese Chemical Letters
  16. MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer
    Shengjie Tang, Shuangjiang Li, Tao Liu, Yiwei He, Haiyang Hu, Yunhe Zhu, Shoujun Tang, Haining Zhou · 2021 · Cancer Letters
  17. The T‐cell fingerprint of MALT 1 paracaspase revealed by selective inhibition
    Maureen Bardet, Adeline Unterreiner, Claire Malinverni, Frédérique Lafossas, Corinne Vedrine, Danielle Boesch, Yeter Kolb, Daniel Kaiser, Anton Glück, Martin A. Schneider et al. · 2017 · Immunology and Cell Biology
  18. The dietary compound luteolin inhibits pancreatic cancer growth by targeting BCL-2
    Zhimei Li, Yiyuan Zhang, Lixia Chen, Hua Li · 2018 · Food & Function
  19. IKAROS and CK2 regulate expression of BCL-XL and chemosensitivity in high-risk B-cell acute lymphoblastic leukemia
    Chunhua Song, Zheng Ge, Yali Ding, Bi‐Hua Tan, Dhimant H. Desai, Krishne Gowda, Shantu Amin, Raghavendra Gowda, Gavin P. Robertson, Feng Yue et al. · 2020 · Blood
  20. Discovery of a Novel BCL-X<sub>L</sub> PROTAC Degrader with Enhanced BCL-2 Inhibition
    Pal, Pratik, Thummuri, Dinesh, Lv, Dongwen, Liu, Xingui, Zhang, Peiyi, Hu, Wanyi, Poddar, Saikat K., Hua, Nan, Khan, Sajid, Yuan, Yaxia et al. · 2021 · Journal of Medicinal Chemistry
  21. Bicyclic Helical Peptides as Dual Inhibitors Selective for Bcl2A1 and Mcl-1 Proteins
    Aline D. de Araujo, Junxian Lim, Kai‐Chen Wu, Yibin Xiang, Andrew C. Good, Renato T. Skerlj, David P. Fairlie · 2018 · Journal of Medicinal Chemistry
  22. Screening Strategies and Methods for Better Off-Target Liability Prediction and Identification of Small-Molecule Pharmaceuticals
    Terry R. Van Vleet, Michael J. Liguori, James J. Lynch, Mohan S. Rao, Scott E. Warder · 2018 · SLAS DISCOVERY
  23. Competing endogenous RNAs in lung cancer
    Meilian Zhao, Jianguo Feng, Liling Tang · 2021 · Cancer Biology and Medicine
  24. ZBP1-Mediated Necroptosis: Mechanisms and Therapeutic Implications
    Xinyu Chen, Yinghong Dai, Xin-xing Wan, Ximin Hu, Wenjuan Zhao, Xiao-xia Ban, Hao Wan, Kun Huang, Qí Zhāng, Kun Xiong · 2022 · Molecules
  25. Bcl-xl as the most promising Bcl-2 family member in targeted treatment of chondrosarcoma
    Yvonne de Jong, David Monderer, Emeline Brandinelli, Morgane Monchanin, Brendy E. van den Akker, Jolieke G. van Oosterwijk, Jean‐Yves Blay, Aurélie Dutour, Judith V.M.G. Bovée · 2018 · Oncogenesis
  26. The anticancer effect of extract of medicinal mushroom Sanghuangprous vaninii against human cervical cancer cell via endoplasmic reticulum stress-mitochondrial apoptotic pathway
    Pingya He, Yuhao Hou, Yue Yang, Ning Li · 2021 · Journal of Ethnopharmacology
  27. Caspase-mediated cleavage of IRE1 controls apoptotic cell commitment during endoplasmic reticulum stress
    Anna Shemorry, Jonathan M Harnoss, Ofer Guttman, Scot A. Marsters, László G. Kömüves, David A. Lawrence, Avi Ashkenazi · 2019 · eLife
  28. Induction of an MLKL mediated non-canonical necroptosis through reactive oxygen species by tanshinol A in lung cancer cells
    Xin Liu, Lele Zhang, Hongwei Gao, Ying Hou, Jin‐Jian Lu, Yulin Feng, Qiongming Xu, Bo Liu, Xiuping Chen · 2019 · Biochemical Pharmacology
  29. The deubiquitinase (DUB) USP13 promotes Mcl-1 stabilisation in cervical cancer
    Ethan L. Morgan, Molly R. Patterson, Diego Barba‐Moreno, James A. Scarth, Adam Wilson, Andrew Macdonald · 2021 · Oncogene
  30. Super Magnetic Niosomal Nanocarrier as a New Approach for Treatment of Breast Cancer: A Case Study on SK-BR-3 and MDA-MB-231 Cell Lines
    Elham Jamshidifar, Faten Eshrati Yeganeh, Mona Shayan, Mohammad Tavakkoli Yaraki, Mahsa Bourbour, Ali Moammeri, Iman Akbarzadeh, Hassan Noorbazargan, Nikoo Hossein‐Khannazer · 2021 · International Journal of Molecular Sciences
  31. Mechanism of Heshouwuyin inhibiting the Cyt c/Apaf-1/Caspase-9/Caspase-3 pathway in spermatogenic cell apoptosis
    Hongjie Wang, Juan Li Zhu, Liping Jiang, Boying Shan, Peihan Xiao, Jiayi Ai, Na Li, Feng Qi, Siyun Niu · 2020 · BMC Complementary Medicine and Therapies
  32. Development and crystal structures of a potent second-generation dual degrader of BCL-2 and BCL-xL
    Digant Nayak, Dongwen Lv, Yaxia Yuan, Peiyi Zhang, Wanyi Hu, Anindita Nayak, Eliza A. Ruben, Zongyang Lv, Patrick Sung, Robert Hromas et al. · 2024 · Nature Communications
  33. Impairing Powerhouse in Colon Cancer Cells by Hydrazide–Hydrazone-Based Small Molecule
    Sohan Patil, Meenu Mahesh Kuman, Sandeep Palvai, Poulomi Sengupta, Sudipta Basu · 2018 · ACS Omega
  34. The Role of the BCL-2 Family of Proteins in HIV-1 Pathogenesis and Persistence
    Aswath P. Chandrasekar, Nathan W. Cummins, Andrew D. Badley · 2019 · Clinical Microbiology Reviews
  35. Programmed Cell Death: Central Player in Fungal Infections
    Giorgio Camilli, Mariana Blagojevic, Julian R. Naglik, Jonathan P. Richardson · 2020 · Trends in Cell Biology
  36. Aberrant Bcl-x splicing in cancer: from molecular mechanism to therapeutic modulation
    Zhihui Dou, Dapeng Zhao, Xiaohua Chen, Caipeng Xu, Xiaodong Jin, Xuetian Zhang, Yupei Wang, Xiaodong Xie, Qiang Li, Cuixia Di et al. · 2021 · Journal of Experimental & Clinical Cancer Research
  37. Targeting the Intrinsic Apoptosis Pathway: A Window of Opportunity for Prostate Cancer
    Daniel Westaby, Juan M. Jiménez‐Vacas, Ana Padilha, Andreas S. Varkaris, Steven P. Balk, Johann Sebastian De Bono, Adam Sharp · 2021 · Cancers
  38. A promising future of metal‐ N ‐heterocyclic carbene complexes in medicinal chemistry: The emerging bioorganometallic antitumor agents
    Qian Zhao, Bo Han, Cheng Yun Peng, Nan Zhang, Wei Huang, Gu He, Jun‐Long Li · 2024 · Medicinal Research Reviews
  39. The BCL-2 protein family: from discovery to drug development
    Carlo Maria Croce, David Lawrence Vaux, Andreas Strasser, Joseph T. Opferman, Peter E. Czabotar, Stephen W. Fesik · 2025 · Cell Death and Differentiation
  40. Senolytic Targeting of Bcl-2 Anti-Apoptotic Family Increases Cell Death in Irradiated Sarcoma Cells
    Julie Lafontaine, Guillaume B. Cardin, Nicolas Malaquin, Jean-Sébastien Boisvert, Françis Rodier, Philip Wong · 2021 · Cancers
  41. PROTACs: Novel tools for improving immunotherapy in cancer
    Shizhe Li, Ting Chen, Jinxin Liu, He Zhang, Jiatong Li, Zhiwei Peter Wang, Guanning Shang · 2023 · Cancer Letters
  42. Quinoxaline derivatives: Recent discoveries and development strategies towards anticancer agents
    Vincent Montero, Marc Montana, Manon Carré, Patrice Vanelle · 2024 · European Journal of Medicinal Chemistry
  43. An investigation on the cytotoxicity and caspase-mediated apoptotic effect of biologically synthesized gold nanoparticles using Cardiospermum halicacabum on AGS gastric carcinoma cells
    Chunfeng Li, Yimin Wang, Hongfeng Zhang, Man Li, Ziyu Zhu, Yingwei Xue · 2019 · International Journal of Nanomedicine
  44. New Quinoline-Based Heterocycles as Anticancer Agents Targeting Bcl-2
    Rania Hamdy, Samia A. Elseginy, Noha I. Ziedan, Arwyn Tomos Jones, Andrew D. Westwell · 2019 · Molecules
  45. Pairing MCL‐1 inhibition with venetoclax improves therapeutic efficiency of BH3‐mimetics in AML
    Myriam Hormi, Rudy Birsen, Maya Belhadj, Tony Huynh, Lilia Cantero-Aguilar, Éric Grignano, Lamya Haddaoui, François Guillonneau, Patrick Mayeux, Mathilde Hunault et al. · 2020 · European Journal Of Haematology
  46. Hydrogen Sulfide Attenuates High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease by Inhibiting Apoptosis and Promoting Autophagy via Reactive Oxygen Species/Phosphatidylinositol 3-Kinase/AKT/Mammalian Target of Rapamycin Signaling Pathway
    Dongdong Wu, Peiyu Zhong, Yizhen Wang, Qianqian Zhang, Jian‐Mei Li, Zhengguo Liu, Ailing Ji, Yanzhang Li · 2020 · Frontiers in Pharmacology
  47. NOXA genetic amplification or pharmacologic induction primes lymphoma cells to BCL2 inhibitor-induced cell death
    Yuxuan Liu, Patrizia Mondello, Tatiana Erazo, Neeta Bala Tannan, Zahra Asgari, Elisa de Stanchina, Gouri J. Nanjangud, Venkatraman Seshan, Shenqiu Wang, Hans‐Guido Wendel et al. · 2018 · Proceedings of the National Academy of Sciences
  48. Polymethoxyflavones from citrus inhibited gastric cancer cell proliferation through inducing apoptosis by upregulating RARβ, both in vitro and in vivo
    Yue Wang, Yunyi Chen, He Zhang, Jiebiao Chen, Jinping Cao, Nanjun Chen, Xian Li, Chongde Sun · 2020 · Food and Chemical Toxicology
  49. Pre-sensitization of Malignant B Cells Through Venetoclax Significantly Improves the Cytotoxic Efficacy of CD19.CAR-T Cells
    Mingya Yang, Lei Wang, Ming Ni, Brigitte Neuber, Sanmei Wang, Wenjie Gong, Tim Sauer, Leopold Sellner, Maria‐Luisa Schubert, Angela Hückelhoven‐Krauss et al. · 2020 · Frontiers in Immunology
  50. Aptamer-Functionalized Dendrimer Delivery of Plasmid-Encoding lncRNA MEG3 Enhances Gene Therapy in Castration-Resistant Prostate Cancer
    Zongguang Tai, Jinyuan Ma, Jianing Ding, Huijun Pan, Rongrong Chai, Congcong Zhu, Zhen Cui, Zhongjian Chen, Quangang Zhu · 2020 · International Journal of Nanomedicine
  51. Aging and Mesenchymal Stem Cells: Therapeutic Opportunities and Challenges in the Older Group
    Huan Chen, Ousheng Liu, Sijia Chen, Yueying Zhou · 2021 · Gerontology
  52. 1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design
    Faheem Faheem, Banoth Karan Kumar, Kondapalli Venkata Gowri Chandra Sekhar, Subhash Chander, Selvaraj Kunjiappan, Sankaranarayanan Murugesan · 2021 · Expert Opinion on Drug Discovery
  53. Fluorination Enhances Serum Stability of Bioreducible Poly(amido amine) Polyplexes and Enables Efficient Intravenous siRNA Delivery
    Gang Chen, Kaikai Wang, Yixin Wang, Pengkai Wu, Minjie Sun, David Oupický · 2017 · Advanced Healthcare Materials
  54. De novo coiled-coil peptides as scaffolds for disrupting protein–protein interactions
    Jordan M. Fletcher, Katherine A. Horner, Gail J. Bartlett, Guto G. Rhys, Andrew John Wilson, Derek N. Woolfson · 2018 · Chemical Science
  55. FLT3-ITD Activates RSK1 to Enhance Proliferation and Survival of AML Cells by Activating mTORC1 and eIF4B Cooperatively with PIM or PI3K and by Inhibiting Bad and BIM
    Daisuke Watanabe, Ayako Nogami, Keigo Okada, Hiroki Akiyama, Yoshihiro Umezawa, Osamu Miura · 2019 · Cancers
  56. Didymin ameliorates dexamethasone-induced non-alcoholic fatty liver disease by inhibiting TLR4/NF-κB and PI3K/Akt pathways in C57BL/6J mice
    Zhongwen Feng, Lijun Pang, Siyun Chen, Xiaohong Pang, Yushen Huang, Qian Qiao, Yinglian Wang, Sayyaphone Vonglorkham, Quanfang Huang, Xing Lin et al. · 2020 · International Immunopharmacology
  57. 225Ac‐labeled CD33‐targeting antibody reverses resistance to Bcl‐2 inhibitor venetoclax in acute myeloid leukemia models
    Ravendra Garg, Kevin J H Allen, Wojciech Dawicki, Eileen M. Geoghegan, Dale L. Ludwig, Ekaterina Dadachova · 2020 · Cancer Medicine
  58. Bcl-2 on the brink of breakthroughs in cancer treatment
    John C. Reed · 2017 · Cell Death and Differentiation
  59. Pooled Genomic Screens Identify Anti-apoptotic Genes as Targetable Mediators of Chemotherapy Resistance in Ovarian Cancer
    Stover, Elizabeth H., Baco, Maria B., Cohen, Ofir, Li, Yvonne Y., Christie, Elizabeth L., Bagul, Mukta, Goodale, Amy, Lee, Yenarae, Pantel, Sasha, Rees, Matthew G. et al. · 2019 · Molecular Cancer Research
  60. Mitochondrial fission factor is a novel Myc-dependent regulator of mitochondrial permeability in cancer
    Jae Ho Seo, Ekta Agarwal, Young Chan Chae, Yu Geon Lee, David S. Garlick, Alessandra Maria Storaci, Stefano Ferrero, Gabriella Gaudioso, Umberto Gianelli, Valentina Vaira et al. · 2019 · EBioMedicine
  61. RETRACTED: Ginsenoside Rg3 inhibits cell growth, migration and invasion in Caco-2 cells by downregulation of lncRNA CCAT1
    Jinliang Li, Yuxi Qi · 2019 · Experimental and Molecular Pathology · Retracted
  62. 18β-Glycyrrhetinic Acid Has Anti-Cancer Effects via Inducing Apoptosis and G2/M Cell Cycle Arrest, and Inhibiting Migration of A549 Lung Cancer Cells
    Ying‐Hua Luo, Cheng Wang, Wanting Xu, Yu Zhang, Tong Zhang, Hui Yi Xue, Yannan Li, Zhong-Ren Fu, Ying Wang, Cheng‐Hao Jin · 2021 · OncoTargets and Therapy
  63. Lysosomal K+ channel TMEM175 promotes apoptosis and aggravates symptoms of Parkinson's disease
    Lili Qu, Bingqian Lin, Wenping Zeng, Chunhong Fan, Haotian Wu, Yushu Ge, Qianqian Li, Canjun Li, Yanan Wei, Jing Xin et al. · 2022 · EMBO Reports
  64. Unlocking the potential of PROTACs: A comprehensive review of protein degradation strategies in disease therapy
    Ritesh P. Bhole, Payal R. Kute, Rupesh V. Chikhale, Chandrakant G. Bonde, Amit Madhaorao Pant, Shailendra Shivaji Gurav · 2023 · Bioorganic Chemistry
  65. BCL2 and BCL(X)L selective inhibitors decrease mitochondrial ATP production in breast cancer cells and are synthetically lethal when combined with 2-deoxy-D-glucose
    Federico Lucantoni, Heiko Düßmann, Irene Llorente‐Folch, Jochen H.M. Prehn · 2018 · Oncotarget
  66. Treating tumors with minimally invasive therapy: A review
    Ping Wang, Suhui Sun, Huide Ma, Sujuan Sun, Duo Zhao, Shumin Wang, Xiaolong Liang · 2019 · Materials Science and Engineering C
  67. Betulinic acid induces autophagy-mediated apoptosis through suppression of the PI3K/AKT/mTOR signaling pathway and inhibits hepatocellular carcinoma.
    Weiping Liu, Shaoling Li, Zi-Ling Qu, Yi Luo, Ruifeng Chen, Su-Fen Wei, Xin Yang, Qi Wang · 2019 · PubMed Central
  68. Design, synthesis and biological evaluation of novel HDAC inhibitors with improved pharmacokinetic profile in breast cancer
    Dahong Yao, Chenyang Li, Jin Jiang, Jian Ming Huang, Jinhui Wang, Zhendan He, Jin Chi Zhang · 2020 · European Journal of Medicinal Chemistry
  69. Synergism of BCL-2 family inhibitors facilitates selective elimination of senescent cells
    David Rysanek, Pavla Vašicová, Jayaprakash Narayana Kolla, David Sedlák, Ladislav Anděra, Jiří Bártek, Zdeněk Hodný · 2022 · Aging
  70. Health Effects of Peptides Extracted from Deer Antler
    Peijun Xia, Dongyue Liu, Yingying Jiao, Zhaoguo Wang, Xi Chen, Shuo Zheng, Jiayuan Fang, Linlin Hao · 2022 · Nutrients
  71. Therapeutic advancements in targeting BCL-2 family proteins by epigenetic regulators, natural, and synthetic agents in cancer
    Arnab Sarkar, Abhik Paul, Tanmoy Banerjee, Avik Maji, Sanjukta Saha, Anupam Bishayee, Tapan Kumar Maity · 2023 · European Journal of Pharmacology
  72. Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment
    Edoardo Peroni, Maria Luigia Randi, Antonio Rosato, Stefano Cagnin · 2023 · Journal of Experimental & Clinical Cancer Research
  73. Extra-mitochondrial prosurvival BCL-2 proteins regulate gene transcription by inhibiting the SUFU tumour suppressor
    Xiaofeng Wu, Li-shu Zhang, Jason E. Toombs, Yi-Chun Kuo, John Tyler Piazza, Rubina Tuladhar, Quinn Barrett, Chih-Wei Fan, Xuewu Zhang, Loren D. Walensky et al. · 2017 · Nature Cell Biology
  74. Reversal Effects of Bound Polyphenol from Foxtail Millet Bran on Multidrug Resistance in Human HCT-8/Fu Colorectal Cancer Cell
    Lu Yang, Shuhua Shan, Hanqing Li, Jiangying Shi, Xiaoli Zhang, Zhuoyu Li · 2018 · Journal of Agricultural and Food Chemistry
  75. Targeting ALK in Cancer: Therapeutic Potential of Proapoptotic Peptides
    Arthur Aubry, Stephane D. Galiacy, M Allouche · 2019 · Cancers
  76. Electroacupuncture Inhibits Apoptosis of Peri-Ischemic Regions via Modulating p38, Extracellular Signal-Regulated Kinase (ERK1/2), and c-Jun N Terminal Kinases (JNK) in Cerebral Ischemia-Reperfusion-Injured Rats
    Jiao Liu, Qin Wang, Shanli Yang, Jia Huang, Xiaodong Feng, Jun Peng, Zhengkun Lin, Weilin Liu, Jing Tao, Lidian Chen · 2018 · Medical Science Monitor
  77. Novel therapeutic strategies to target leukemic cells that hijack compartmentalized continuous hematopoietic stem cell niches
    Vashendriya V.V. Hira, Cornelis J.F. Van Noorden, Hetty E. Carraway, Jaroslaw Pawel Maciejewski, Remco Jurriaan Molenaar · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  78. Approaching Target Selectivity by De Novo Drug Design
    Thomas Fischer, Silvia Gazzola, Rainer Riedl · 2019 · Expert Opinion on Drug Discovery
  79. A Multifunction Lipid-Based CRISPR-Cas13a Genetic Circuit Delivery System for Bladder Cancer Gene Therapy
    Jing Fan, Yuchen Liu, Lisa Liu, Yikun Huang, Xuemei Li, Weiren Huang · 2019 · ACS Synthetic Biology
  80. Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice
    N. Anstee, R. Bilardi, Ashley P Ng, Zhen Xu, M. Robati, C. Vandenberg, S. Cory · 2018 · Cell Death and Differentiation
  81. Resveratrol induces human colorectal cancer cell apoptosis by activating the mitochondrial pathway via increasing reactive oxygen species
    Yun Fu, Yuedian Ye, Guifang Zhu, Yangwei Xu, Jingbo Sun, Hongmei Wu, Feiyan Feng, Zhihui Wen, Shanshan Jiang, Yanyan Li et al. · 2020 · Molecular Medicine Reports
  82. Expanding the Limits of Photodynamic Therapy: The Design of Organelles and Hypoxia-Targeting Nanomaterials for Enhanced Photokilling of Cancer
    Italo Rodrigo Calori, Hong Bi, Antônio Cláudio Tedesco · 2021 · ACS Applied Bio Materials
  83. Mitochondrially targeted tamoxifen in patients with metastatic solid tumours: an open-label, phase I/Ib single-centre trial
    Zuzana Bielčiková, Jan Štursa, Ľudmila Křížová, Lan‐Feng Dong, Jiří Špaček, Stanislav Hloušek, Michal Vočka, Kateřina Rohlenová, Olga Bartošová, Vladimír Černý et al. · 2023 · EClinicalMedicine
  84. Overview of BCL-2 Family Proteins and Therapeutic Potentials
    Jason D. Huska, Heather M. Lamb, J. Marie Hardwick · 2018 · Methods in molecular biology
  85. Over high or low dietary protein levels depressed the growth, TOR signaling, apoptosis, immune and anti-stress of abalone Haliotis discus hannai
    Shuoli Ma, Yanlin Guo, Li Sun, Wenhao Fan, Yue Liu, Danni Liu, Dong Huang, Xinxin Li, Wenbing Zhang, Kangsen Mai · 2020 · Fish & Shellfish Immunology
  86. Vitamin-B12-conjugated PLGA-PEG nanoparticles incorporating miR-532-3p induce mitochondrial damage by targeting apoptosis repressor with caspase recruitment domain (ARC) on CD320-overexpressed gastric cancer
    Zhian Chen, Yanrui Liang, Xiaoli Feng, Liang Yu, Guodong Shen, Huilin Huang, Zhaoyu Chen, Jiang Yu, Hao Liu, Lin Tian et al. · 2020 · Materials Science and Engineering C
  87. Exploring the selectivity of inhibitor complexes with Bcl-2 and Bcl-XL: A molecular dynamics simulation approach
    Naoki Wakui, Ryunosuke Yoshino, Nobuaki Yasuo, Masahito Ohue, Masakazu Sekijima · 2017 · Journal of Molecular Graphics and Modelling
  88. Antiviral Properties of Chemical Inhibitors of Cellular Anti-Apoptotic Bcl-2 Proteins
    Daria R. Bulanova, Aleksandr Ianevski, Andrii Bugai, Yevhen A. Akimov, Suvi H. Kuivanen, Henrik Paavilainen, Laura Kakkola, Jatin Nandania, Laura Turunen, Tiina Öhman et al. · 2017 · Viruses
  89. Pharmacophore hybridization approach to discover novel pyrazoline-based hydantoin analogs with anti-tumor efficacy
    Neha Upadhyay, Kalpana N. Tilekar, Fulvio Loiodice, N. Yu. Anisimova, Tatiana S. Spirina, Darina V. Sokolova, Galina B. Smirnova, Jun‐yong Choe, Franz‐Josef Meyer‐Almes, Vadim S. Pokrovsky et al. · 2020 · Bioorganic Chemistry
  90. Inhibitors of BCL2A1/Bfl-1 protein: Potential stock in cancer therapy
    Xue Li, Junwei Dou, Qidong You, Zhengyu Jiang · 2021 · European Journal of Medicinal Chemistry
  91. LncRNA ACART protects cardiomyocytes from apoptosis by activating PPAR‐γ/Bcl‐2 pathway
    Hao Wu, Haixia Zhu, Yuting Zhuang, Jifan Zhang, Xin Ding, Linfeng Zhan, Shenjian Luo, Qi Zhang, Fei Sun, Mingyu Zhang et al. · 2019 · Journal of Cellular and Molecular Medicine
  92. Regulation of stressed-induced cell death by the Bcl-2 family of apoptotic proteins
    Rabih Roufayel · 2016 · Molecular Membrane Biology
  93. The novel TRAIL-receptor agonist APG350 exerts superior therapeutic activity in pancreatic cancer cells
    Karen Legler, Charlotte Hauser, Jan‐Hendrik Egberts, Anna Willms, Carola Heneweer, Susann Boretius, Christoph Röcken, Claus‐Christian Glüer, Thomas Becker, Michael Kluge et al. · 2018 · Cell Death and Disease
  94. Marine macroalga Caulerpa: role of its metabolites in modulating cancer signaling
    Richa Mehra, Satej Bhushan, Felix Bast, Sandeep Singh · 2019 · Molecular Biology Reports
  95. Perfluorooctanoic acid (PFOA) inhibits the gap junction intercellular communication and induces apoptosis in human ovarian granulosa cells.
    Yuan-Yuan Zhou, Hong-Ping Li, Chuan-Ping Lin, Yu-Chan Mao, Jin-Peng Rao, Yi-yun Lou, Xin-Yun Yang, Xiang-rong Xu, F. Jin · 2020 · Reproductive Toxicology
  96. PROTAC-Mediated Dual Degradation of BCL-xL and BCL-2 Is a Highly Effective Therapeutic Strategy in Small-Cell Lung Cancer
    Sajid Ullah Khan, Lin Sen Cao, Janet S. Wiegand, Peiyi Zhang, Maria Zajac‐Kaye, Frederic J. Kaye, Guangrong Zheng, Daohong Zhou · 2024 · Cells
  97. Targeting Focal Adhesion Kinase Using Inhibitors of Protein-Protein Interactions
    Antoine Mousson, Émilie Sick, Philippe Carl, Denis Dujardin, Jan De Mey, Philippe Rondé · 2018 · Cancers
  98. Venetoclax for the treatment of multiple myeloma
    Iuliana Vaxman, M Hasib Sidiqi, Morie Abraham Gertz · 2018 · Expert Review of Hematology
  99. Targeting CARD6 attenuates spinal cord injury (SCI) in mice through inhibiting apoptosis, inflammation and oxidative stress associated ROS production
    Jiang Lin Wang, Xiao Luo, Li Liu · 2019 · Aging
  100. Quercetin, chrysin, caffeic acid and ferulic acid ameliorate cyclophosphamide-induced toxicities in SH-SY5Y cells
    Adnan Ayna, Seda Nur Özbolat, Ekrem Darendelioğlu · 2020 · Molecular Biology Reports